In a previous study, we showed that TTG-IgA titer correlated with enteropathy in CeD patients detected by mass screening, and we proposed that the no-biopsy approach to diagnose CeD may be of use in screening-detected children from the general population with a TTG-IgA titer > 10× ULN given EMA positivity (28). The gene discussed is CD79A; the disease is Abnormal intestine morphology.